REG - Abbott Laboratories - Announcement of Intention to Delist <Origin Href="QuoteRef">ABT.N</Origin>
RNS Number : 4746KAbbott Laboratories21 September 2016
Statement re: Intention to Cancel Listing
21 September 2016
INTENTION TO CANCEL LISTING OF SHARES
Abbott Laboratories hereby announces that it has applied for the cancellation of the listing of its common shares without par value on the Official List, which will result in the cancellation of the trading of its common shares on the London Stock Exchange, to take effect on 21 October 2016.
This notice is given in fulfilment of the obligation under LR 5.2.8.
Scott Leinenweber, Vice President, Investor Relations, +1-224-668-0791
Scott Stoffel, Divisional Vice President, External Communications, +1-224-668-5201
This information is provided by RNSThe company news service from the London Stock ExchangeENDSTRLLFEVASILFIR
Recent news on Abbott LaboratoriesSee all news
ABBOTT LABORATORIES INVESTIGATION REMINDER ALERT: Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories’ Directors and Officers for Breach of Fiduciary Duties – ABTNews
News News News News